Iom Bioworks, a Bengaluru-based deep science company focused on microbiome-based healthcare, has raised ₹4 crore in a Seed Round led by Inflection Point Ventures (IPV). The company will use the capital to expand its marketing efforts, secure intellectual property rights, strengthen its core infrastructure, and scale both its scientific and commercial teams.
Revolutionizing Health Through Gut Microbiome Science
Founded in 2022, Iom Bioworks personalizes healthcare by identifying and modulating key gut bacteria to enhance overall well-being. The company has developed a patented platform that integrates artificial intelligence (AI), large-scale knowledge graphs, and advanced modelling techniques. This powerful combination enables Iom to deliver precise and personalized health recommendations to its users.
Rapid Growth and Scientific Credibility
In its first year alone, Iom Bioworks served over 500 customers. The company already holds two granted patents and has two more in advanced stages. Additionally, it has published research in leading scientific journals, showcasing its deep scientific foundation. With a pan-India logistics network and fully digital access, Iom delivers personalized microbiome services conveniently across the country.
Strong Leadership Driving Innovation
Iom Bioworks is led by a team of global experts:
- Bipin Pradeep Kumar, Co-Founder & CEO, brings a strategic and collaborative approach, fusing microbiome science with AI and customer-centered design.
- Dr. Samik Ghosh, Co-Founder & Chief of Science & Technology, uses his expertise in computational biology to develop innovative, sustainable microbiome-based health solutions.
- Dr. Hiroaki Kitano, Co-Founder & Chief of Research & Collaboration, is a globally renowned systems biologist and AI leader, known for his work in robotics and scientific discovery.
Backed by a Visionary Investment Partner
As per the press release, Vinay Bansal, Founder of IPV, expressed strong support for Iom’s vision:
“Lifestyle diseases are rising due to poor diet, stress, and lack of sleep—all linked to gut health. The gut microbiome affects digestion, immunity, metabolism, and even mood. Iom Bioworks is making this science accessible and actionable, positioning itself as a leader in preventive and therapeutic healthcare.”
Empowering Health Through Informed Choices
Commenting on the funding, Bipin Pradeep Kumar said:
“Iom Bioworks envisions a world where a healthy mind and body come from nurturing the microbiome. Our approach—rooted in prebiotics, food, and lifestyle—energizes life while preserving its joy. Partnering with IPV has been pivotal. Their support and diligence have reinforced our journey toward this vision.”
Tapping into a Fast-Growing Wellness Market
The global market for health tests, subscriptions, and wellness platforms is projected to reach USD 900 billion by 2030, growing at a CAGR of 28%. With its scientific foundation, scalable platform, and user-focused approach, Iom Bioworks is poised to lead the transformation toward accessible, personalized gut health solutions.